Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Actinogen Medical Ltd
F:3AC
Actinogen Medical Ltd
F:3AC
Price:
0.031
EUR
-17.11%
Market Cap:
€84.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Actinogen Medical Ltd
F:3AC
|
AU |
|
D
|
Defence Therapeutics Inc
F:DTC
|
CA |
|
S
|
Shrinkflex (Thailand) PCL
SET:SFT
|
TH |
|
S
|
Siamese Asset PCL
SET:SA
|
TH |
|
G
|
Gatekeeper Systems Inc
F:1GK
|
CA |
|
E
|
East Africa Metals Inc
OTC:EFRMF
|
CA |
|
Norseman Silver Inc
XTSX:FTZ
|
CA |
|
T
|
transcosmos Inc
XMUN:TSQ
|
JP |
|
Columbia Care Inc
F:3LP
|
US |
|
S
|
Sunsweet PCL
SET:SUN
|
TH |
Wall St Price Targets
3AC Price Forecast
Based on 3 analysts
Based on 3 analysts
-16% Downside
from
€0.031
today
Actinogen Medical Ltd (3AC)’s 12-month stock price forecast through October 2027 has a consensus target of €0.026, implying 16% downside. The forecast is based on price targets from 3 Wall Street analysts.
3AC Analyst Rating
No ratings yet
No ratings yet
Actinogen Medical Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3AC's stock price target?
Price Target
0.026
EUR
0.026
EUR
According to Wall Street analysts, the average 1-year price target for 3AC is 0.026 EUR with a low forecast of 0.026 EUR and a high forecast of 0.027 EUR.